Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

NCT00004197 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: keyhole limpet hemocyanin
BIOLOGICAL: sargramostim
BIOLOGICAL: tumor cell-based vaccine therapy
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: mitoxantrone hydrochloride
DRUG: prednisone
DRUG: vincristine sulfate

Sponsor

University of Nebraska

Collaborators

[object Object]